Glycodendritic structures as DC-SIGN binders to inhibit viral infections.
2021
DC-SIGN, a lectin discovered two decades ago, plays a relevant role in innate immunity. Since its discovery, it has turned out to be a target for developing antiviral drugs based on carbohydrates due to its participation in the infection process of several pathogens. A plethora of carbohydrate multivalent systems using different scaffolds have been described to achieve this goal. Our group has made significant contributions to this field, which are revised herein.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
101
References
1
Citations
NaN
KQI